StocksMarket.in

Tag "Biotech"

 Breaking News

Buzzing Stocks | Deepak Nitrite, Rossari Biotech and others that will be in focus today

Check out the companies making the biggest headlines before the bell Rossari Biotech | The company’s board approved issuance of 30,12,046 equity shares on a preferential basis at a price

Read Full Article

Premas Biotech, Oramed to develop potential COVID-19 vaccine pill

Oravax’s COVID-19 vaccine candidate which is a triple antigen virus like particle (VLP) consists three structural proteins of SARS-CoV2, unlike most other vaccines that are based on Spike (S) protein.

Read Full Article

Strides#39; biotech division Stelis to make 200 million doses of Russia#39;s Sputnik V vaccine

The parties intend to commence supplies from Q3 2021. Stelis will also continue to work with Russia’s sovereign wealth fund RDIF to provide additional supply volumes beyond the initial agreement.

Read Full Article

Bharat Biotech strikes deal with Brazil to supply 20 million doses of Covaxin

The deal would be a shot in the arm for Bharat Biotech, which is looking for markets beyond India to sell its vaccine. Bharat Biotech’s Covaxin was granted restricted emegency

Read Full Article

Bharat Biotech enters pact with GSK, PATH to produce, distribute malaria vaccine

Bharat Biotech, UK drug giant GSK and US-based non-profit PATH on January 27 announced the signing of a product transfer agreement for the malaria vaccine. As per the agreement, GSK

Read Full Article

Rossari Biotech: Market share gain in textile chemicals is comforting

In the longer term, what we like about Rossari Biotech is that it’s led by technocrats with strong domain knowledge, which in turn has helped in superior execution of capex

Read Full Article

What is informed consent form for Bharat Biotech Covaxin, what information is sought in the form and other questions answered

Bharat Biotech’s Covaxin was granted restricted emegency use approval in ‘clinical trial mode’ on January 2. Bharat Biotech’s COVID-19 vaccine

Read Full Article

Bharat Biotech says it has recruited 8,000 participants in phase-3, justifies seeking emergency use approval

1 | Pfizer, BioNTech COVID-19 vaccine 95% effective in final results, shows study: Pfizer Inc on November 18 said its

Read Full Article

Goldman Sachs ups stake in Rossari Biotech, Norges Bank raises holding in IndiaMART

Goldman Sachs India on July 23 acquired an additional 0.92 percent stake in specialty chemical maker Rossari Biotech via open

Read Full Article

Rossari Biotech hits upper circuit intraday, closes Day 1 with 75% gains at Rs 742.35

Specialty chemical maker Rossari Biotech witnessed tremendous demand on its first day of trade on July 23 with the stock hitting

Read Full Article

Rossari Biotech debuts at Rs 670 with 58% premium over IPO price

The Mumbai-based specialty chemical maker Rossari Biotech started the first trading day with a whopping 57.65 percent premium over its

Read Full Article

Subscribe to Rossari Biotech: Ajcon Research

Ajcon Research Rossari Biotech Started in CY03 as “Rossari Lab tech”, a partnership firm, Rossari was converted to Company in

Read Full Article

Subscribe to Rossari Biotech: Choice Equity Broking

Choice Equity Broking has come out with its report on Rossari Biotech. The research firm has recommended to “Subscribe” the

Read Full Article

Subscribe to Rossari Biotech: Anand Rathi

Anand Rathi has come out with its report on Rossari Biotech. The research firm has recommended to “Subscribe” the IPO

Read Full Article

Subscribe to Rossari Biotech: Hem Securities

Hem Securities has come out with its report on Rossari Biotech. The research firm has recommended to “Subscribe” the IPO

Read Full Article

Subscribe to Rossari Biotech: Arihant Capital

Arihant Capital has come out with its report on Rossari Biotech. The research firm has recommended to “Subscribe” the IPO

Read Full Article

Subscribe to Rossari Biotech: Mehta Equities

Mehta Equities has come out with its report on Rossari Biotech. The research firm has recommended to “Subscribe” the IPO

Read Full Article

Rossari Biotech IPO subscribed 3 times on Day 2 amid retail, QIB interest

Mumbai-based specialty chemical maker Rossari Biotech’s initial public offering has fully subscribed on July 14, the second day of bidding,

Read Full Article

Rossari Biotech IPO subscribed 1.21 times on Day 2 amid retail, QIB interest

Mumbai-based specialty chemical maker Rossari Biotech’s initial public offering has been fully subscribed on July 14, the second day of

Read Full Article

Archives